Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 15, 2018
Immunohistochemical Expression of Cortactin and Focal Adhesion Kinase Predicts Recurrence Risk and Laryngeal Cancer Risk Beyond Histologic GradingM Ángeles Villaronga, Francisco Hermida-Prado, Rocío Granda-Díaz, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 17, 2023
Targeting oncogenic functions of miR-301a in head and neck squamous cell carcinoma by PI3K/PTEN and MEK/ERK pathwaysRocío Granda-Díaz, Lorea Manterola, Francisco Hermida-Prado, et al.
Cancers|September 20, 2018
Factors Secreted by Cancer-Associated Fibroblasts that Sustain Cancer Stem Properties in Head and Neck Squamous Carcinoma Cells as Potential Therapeutic TargetsSaúl Álvarez-Teijeiro, Cristina García-Inclán, M Ángeles Villaronga, et al.
International Journal of Molecular Sciences|March 13, 2024
Combined PIK3CA and SOX2 Gene Amplification Predicts Laryngeal Cancer Risk beyond Histopathological GradingIrene Montoro-Jiménez, Rocío Granda-Díaz, Sofía T Menéndez, et al.
Oncotarget|April 28, 2016
Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomasDarío García-Carracedo, Maria Ángeles Villaronga, Saúl Álvarez-Teijeiro, et al.
NPJ Breast Cancer|June 8, 2024
Pure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancerAlbert Grinshpun, Douglas Russo, Wen Ma, et al.
Journal of Clinical Medicine|December 6, 2018
Distinctive Expression and Amplification of Genes at 11q13 in Relation to HPV Status with Impact on Survival in Head and Neck Cancer PatientsFrancisco Hermida-Prado, Sofía T Menéndez, Pablo Albornoz-Afanasiev, et al.
Neoplasia (New York, N.Y.)|December 1, 2017
FUS-CHOP Promotes Invasion in Myxoid Liposarcoma through a SRC/FAK/RHO/ROCK-Dependent PathwayJuan Tornin, Francisco Hermida-Prado, Ranjit Singh Padda, et al.
Journal of Clinical Medicine|August 7, 2019
The SRC Inhibitor Dasatinib Induces Stem Cell-Like Properties in Head and Neck Cancer Cells that are Effectively Counteracted by the Mithralog EC-8042Francisco Hermida-Prado, M Ángeles Villaronga, Rocío Granda-Díaz, et al.
Signal Transduction and Targeted Therapy|November 5, 2025
CDK7-targeted therapy effectively disrupts cell cycle progression and oncogenic signaling in head and neck cancerMaría Otero-Rosales, Miguel Álvarez-González, Irene Pazos, et al.
Pageof 4